As per available reports about 40 relevant journals, 30 Conferences, 562 workshops are presently dedicated exclusively to breathing disorder and about 778 articles are being published on Infectious Diseases.

An Opportunistic Infection is a disease brought about by pathogens, especially crafty pathogens—those that exploit certain circumstances, for example, bacterial, viral, parasitic or protozoan diseases that generally don't result in malady in a sound have, unified with a solid invulnerable framework. A compromised immune system, nonetheless, displays an "opportunity" for the pathogen to contaminate.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance

Immunodeficiency or immunosuppression can be caused by Malnutrition, Fatigue, Recurrent infections, Immunosuppressing agents for organ transplant recipients, Advanced HIV infection, Chemotherapy for cancer, Genetic predisposition, Skin damage, Antibiotic treatment, Medical procedures, Pregnancy.

Types of infections

1) Acinetobacter baumanni- Acinetobacter baumannii is a typically short, almost round, rod-shaped Gram-negative bacterium. It can be an opportunistic pathogen in humans, affecting people with compromised immune systems, and is becoming increasingly important as a hospital-derived infection.

2) Aspergillus sp.- Aspergillus is a member of the deuteromycetes fungi, which is a group with no known sexual state. With DNA evidence forthcoming, it is likely that all members of the genus Aspergillus are closely related and should be considered members of the Ascomycota.

3) Candida albicans- Candida albicans is a diploid fungus that grows both as yeast and filamentous cells and a causal agent of opportunistic oral and genital infections in humans and candida onychomycosis, an infection of the nail plate. Systemic fungal infections including those by C. albicans have emerged as important causes of morbidity and mortality in immunocompromised patients.

4) Clostridium difficile- Clostridium difficile diarrhea (from the Greek kloster "spindle" and Latin difficile, is a type of infectious diarrhea caused by the bacteria Clostridium difficile. Clostridium difficile is also known as CDF/cdf, or C. diff, is a species of Gram-positive spore-forming bacteria.

5) Cryptococcus neoformans- Cryptococcus neoformans is an encapsulated yeast that can live in both plants and animals. Its teleomorph is Filobasidiella neoformans, a filamentous fungus belonging to the class Tremellomycetes. It is often found in pigeon excrement.

6) Cryptosporidium- Cryptosporidium is a genus of apicomplexan protozoans that can cause gastrointestinal illness with diarrhea in humans. Cryptosporidium is the organism most commonly isolated in HIV-positive patients presenting with diarrhea.

7) Cytomegalovirus- Cytomegalovirus from the Greek cyto-, "cell", and -megalo-, "large" is a viral genus of the viral family known as Herpesviridae or herpesviruses. It is typically abbreviated as CMV.

8) Geomyces destructans- Geomyces destructans is a psychrophilic (cold-loving) fungus that causes white-nose syndrome (WNS), a fatal disease that has decimated bat populations in parts of the United States and Canada. Unlike other species of Geomyces, P. destructans forms asymmetrically curved conidia.

9) Histoplasma capsulatum- Histoplasma is a genus of dimorphic fungi commonly found in bird and bat fecal material. Histoplasma contains a few species, including—H. capsulatum—the causative agent of histoplasmosis; and Histoplasma capsulatum var. farciminosum (old term, Histoplasma farciminosum), causing epizootic lymphangitis in horses.

10) Isospora belli- Isospora belli is a species of internal parasites classified under Coccidia. It is responsible for the condition isosporiasis. Autofluorescence aids detection.

11) Polyomavirus JC polyomavirus, the virus that causes Progressive multifocal leukoencephalopathy.

12) Microsporidium-The microsporidia constitute a phylum of spore-forming unicellular parasites. They were once thought to be protists but are now known to be fungi.

13) Pseudomonas aeruginosa- Pseudomonas aeruginosa is a common bacterium that can cause disease in animals, including humans. It is citrate, catalase, and oxidase positive.

14) Streptococcus pyogenes- Streptococcus pyogenes is a spherical, Gram-positive bacterium that is the cause of group A streptococcal infections S. pyogenes displays streptococcal group A antigen on its cell wall and typically produces large zones of beta-hemolysis

Market Analysis

Infectious diseases therapeutic market

The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America has the more global market for infectious diseases therapeutics due to increasing incidence of infectious diseases and due to rise in aging population. Followed by North America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. In Asia-Pacific region, China and India are expected to be the fastest growing infectious diseases therapeutics markets. The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Some of the major companies playing a key role in the global infectious diseases therapeutics market are Merck & Co., Pfizer, Johnson & Johnson, F. Hoffmann-La Roche, GlaxoSmithKline Pharmaceutical, Inc., Auritec Pharmaceuticals, Novartis, Achillion Pharmaceuticals, Isis Pharmaceuticals and Gilead Sciences.

Infectious diseases diagnostics market

Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories. North America has the highest global market for molecular diagnostics tests followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years. Major companies which play a key role in infectious disease molecular diagnostics tests market are Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson and Company, bioMérieux, Cepheid, Inc., Hologic, Inc., Life Technologies, Myriad Genetics, Inc., Qiagen N.V. and others.